Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III single-blind study of INC056 for vaginal dryness and local irritability
ISRCTN64791295Phase 3Completed
- Sponsor
- Incrementha PD&I
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of INC056 in vaginal dryness and None, sponsored by Incrementha PD&I. Primary endpoint: Vaginal acidification. Started Oct 2008; status: completed.
02
Drugs
INC056
03
Conditions
vaginal dryness
Beyond the preview
Go deeper on ISRCTN64791295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64791295.